106 EAST 6TH STREET, SUITE 900-145, AUSTIN, TX
Reg. FD
Investor Presentation
Ex-99.1
Earnings Release
Core Scientific Elects Five Directors at 2026 Annual Meeting
Q2
Q1
Amended Annual Report
Amended Quarterly Report
FY 2025
Prospectus Filed Pursuant to Rule 425
Definitive Proxy Statement
Additional Proxy Materials
Definitive Additional Information Statement
Contested Proxy Solicitation Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities